{"id":"W2060481687","doi":"10.1016/j.critrevonc.2014.08.001","title":"Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis","year":2014,"lang":"en","type":"review","venue":"Critical Reviews in Oncology/Hematology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"Associazione Italiana per la Ricerca sul Cancro; Ministero dell’Istruzione, dell’Università e della Ricerca","keywords":"Benchmarking; Renal cell carcinoma; Medicine; Oncology; Clinical endpoint; Internal medicine; Progression-free survival; Clinical trial; Overall survival; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01988318,0.0008861565,0.006887352,0.00159254,0.0001388728,0.001421507,0.001992764,0.001124124,0.001742707],"category_scores_gemma":[0.03636642,0.0004454173,0.003810817,0.002187793,0.0007418466,0.001082816,0.0005832068,0.002078466,0.0002975641],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001198093,"about_ca_system_score_gemma":0.001466597,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007138345,"about_ca_topic_score_gemma":0.001632419,"domain_scores_codex":[0.9897003,0.006154657,0.001971326,0.0006200536,0.001436112,0.0001175232],"domain_scores_gemma":[0.9535539,0.04186707,0.002808757,0.0004377917,0.001188039,0.0001445684],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.002723278,0.000073697,0.0009626676,0.1348525,0.009077621,0.00004527041,0.00006508329,0.001709359,0.0004732033,0.002903547,0.007156043,0.8399577],"study_design_scores_gemma":[0.0148309,0.01133498,0.03385786,0.2657864,0.1305678,0.003047019,0.0005128866,0.00848499,0.004540638,0.04932245,0.47722,0.0004939989],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003369398,0.998609,0.0004603926,0.0002205901,0.00008851572,0.00004170733,0.0000450247,0.000004697984,0.0001932005],"genre_scores_gemma":[0.0160118,0.9802434,0.002160152,0.0006536277,0.0003792503,0.0002463293,0.0001392478,0.00001236972,0.0001538097],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9801168,"threshold_uncertainty_score":0.1051536,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1220761889246877,"score_gpt":0.4811848597624934,"score_spread":0.3591086708378057,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}